Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Humira
Pharma
With $5.5B sales, AbbVie's Skyrizi matches Humira's best quarter
AbbVie's Skyrizi generated sales of $5.55B in Q2, matching the most ever achieved in a quarter by the company's immunology predecessor Humira.
Kevin Dunleavy
Jul 31, 2026 11:18am
How biosimilar developers are embracing next phase of US market
Jul 6, 2026 10:03am
AbbVie shrugs off new J&J competition for fast-growing Skyrizi
Apr 29, 2026 2:53pm
AbbVie launches ‘PSO Done’ psoriasis campaign
Apr 20, 2026 8:03am
AbbVie touts Skyrizi, Rinvoq prowess amid J&J IBD competition
Feb 4, 2026 2:52pm
AbbVie locks in US pricing deal as it pledges $100B investment
Jan 13, 2026 9:15am
